Search
SOLACI Congress
HomeCONGRESS

CONGRESS

View Category
Acute coronary syndromes

ESC 2025 | DUAL-ACS: Duration of Dual Antiplatelet Therapy in Acute Coronary Syndromes

The DUAL-ACS trial, a randomized multicenter study, was designed to evaluate whether a strategy of P2Y12 inhibitor...
Dr. Juan Manuel Pérez -
Learn More
Peripheral vascular disease

ESC 2025 | SWEDEPAD 1 and 2: Paclitaxel-Coated Devices in Peripheral Artery Disease

In patients with peripheral artery disease, “improving” prognosis means relieving walking pain, increasing walking distance, preventing amputations,...
Dr. Juan Manuel Pérez -
Learn More
Acute coronary syndromes

ESC 2025 | OPTION-STEMI: Timing of Complete Revascularization During the Initial Hospitalization in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease

In patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease (MVD), the optimal timing...
Dr. Juan Manuel Pérez -
Learn More
Coronary Disease

ESC 2025 | PULSE: Coronary CT Angiography vs Ischemia-Guided Follow-Up After Unprotected Left Main PCI

Courtesy of Dr. Juan Manuel Pérez. Unprotected left main (ULM) percutaneous coronary intervention (PCI) remains associated with a...
Dr. Juan Manuel Pérez -
Learn More
Events

Save the Date! CardioInterv 2025 – 25th International Symposium on Interventional Cardiology is Coming

From November 26 to 28, 2025, the 25th International Symposium on Interventional Cardiology – CardioInterv 2025 will...
solaci -
Learn More
Institutional News

SOLACI-SOCIME 2025: Day 3 Highlights

The third and final day of the SOLACI-SOCIME 2025 Congress concluded with a high-impact scientific agenda, featuring...
solaci -
Learn More
Institutional News

SOLACI-SOCIME 2025 Congress Certificates

You can now download both your attendance certificate and scientific participation certificate from the SOLACI-SOCIME 2025 Congress,...
solaci -
Learn More
Institutional News

New Session of the MIL Group at the SOLACI-SOCIME 2025 Congress

As part of the SOLACI-SOCIME 2025 Congress, the largest interventional cardiology event in Latin America, the Latin...
solaci -
Learn More

SOLACI is the reference organization for Latin American cardiovascular interventionism.

Last News

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Dr. Omar Tupayachi - 0
Coronary perforations remain one of the most serious complications of percutaneous coronary intervention (PCI), especially in cases of Ellis ruptures type III. In these...

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Is it really necessary to monitor all patients after TAVR?

Dr. Juan Manuel Pérez - 0
Conduction disorders (CD) after transcatheter aortic valve replacement (TAVR) are a frequent complication and may lead to the need for permanent pacemaker implantation (PPI)....

Institutional News

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

solaci - 0
Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

solaci - 0
Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

solaci - 0
The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

Access

Adolfo Alsina 2653 · Piso 2H · CABA · Buenos Aires · Argentina · (5411) 4954 7173 · info@solaci.org · solaci.org · Terms of Use -Privacy Policy